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Abstract. Background: We have previously reported that 
azulene-related compounds, and alkaline extract of Sasa 
senanensis Rehder potently inhibited nitric oxide (NO) 
productlon by lipopolysaccharide (LPS)-stimulated mouse 
macrophages. We investigated here whether they can inhibit 
pro-inflammatory cytokine production, by activated human 
gingival fibroblast (HGF). Materials and Methods: HGF was 
established from the periodontal tissues of extracted tooth. 
Vlable cell number was determined by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. 
Production of Prostaglandin E2 (PGE2) and cytokines was 
determined by enzyme immunoassay, and enzyme-linked 
immunosorbent assay, respectively. Results: Interleukin (IL)-
lp did not inhibit, but rather slightly stimulated the growth of 
HGF cells. IL-1p stimulated the production of PGE2, IL-6, IL-
8 and monocyte chemotactic protein-1 very potently, but not 
that of nitric oxide and tumor necrosis factor-a. Native LPS 
and synthetic lipid A from E. coli and P. gingivalis was much 
less stimulatory. Dexamethasone, not indomethacin, was an 
efficient inhibitor of IL-8 production. Among five azulene-
related compounds, benzo[bJcycloheptafeJfl ,4Jthiazine most 
potently inhibited the IL-8 production by HGF cells, as well 
as NO production by activated RAW264.7 cells. The alkaline 
extract of Sasa senanensis Rehder sigmficantly inhibited IL-8 
production, without affecting the cell viability. Conclusion: 
The present system may be applicable for use in the search for 
a,nti-gingivitis substances. 
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Chemotherapy and radiother py, while highly effective in the 
treatment of neoplast, adversely affect the epithelia of oral 
mucosa, causing sever inflammation, Iesioning, ulceration 
and bleeding in the mouth (1). The cause of stomatitis is 
unknown and thought to be multifactorial with many triggers 
or precipitating fac ors . The risk factors include the poor oral 
hygiene, secondary infection of both Gram-positive and 
Gram-n gative b ria, Iow rates of salivary production, 
poor production of mucins, antimicrobial-, anti-fungal and 
anti-viral factors, impaired local or systemic immunity, and 
age/gender (2) . Sinc  some risk factors for stomatitis and 
those for oral cancer are common between the two diseases 
overlapped wi h each other (3), there is a possibility that 
stomati s m y trigger the carcinogenesis of oral cancer. It is 
therefore very important to establish an in vitro assay system 
for the measurement of a ti-stomatitis activity. For this 
purpose, as he first part of the present study, we investigated 
here several stimulators for their ability to induce the 
production of pro-infl mmatory substances in human 
ging val fibroblast (HGF) c lls. 
We have previously reported that benzo[b]cyclo-
hepta[e][1,4]thiazine [1], 6,8-dibromobenzo[b]cyclohepta 
[e][1,4]thiazine [2] (4) , benzo[b]cyclohept[e][1,4]oxazin-
6(1 IH)-one L5] (5), 3-methyl-1-trichloroacetylazulene [2b] 
and 3-ethyl-1-trichloroacetylazulene [3b] (6) (Figure 1) 
inhibited nitric oxide (NO) production by lipopolysaccharide 
(LPS)-activated mouse macrophage-1ike RAW264.7 cells 
(Table I) . Similarly, alkaline extract of the leaves of Sasa 
senanensis Rehder or Sasa albo-marginata Makino et Shibata 
(SE) (SASA-HealthR) inhibited NO and prostaglandin E2 
(PGE2) production by activated macrophages via inhibition 
of inducible NO synthase and cyclooxygenase-2 expression 
at both protein and mRNA Ievels (7) (Table I). As the second 
part of our study, we investigated here whether these 
co pounds and SE can effectively inhibit the production of 
pro-infl mmatory cytokines by HGF. 
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Figure I . Chemical structure of group 11 compounds: benzofb]cyclohepta[e][1 ,4]thiazine [1], 6,8-dibromobenzo[b]cyclohepta[e][1 ,4]thiazine [2], 
benzo[b]cyclohepta[e]fl ,4]oxazin-6(11H)-one [5], 3-methyl-1-trichloroacetylazulene [2b], 3-ethyl-1-trichloroacetylazulene [3b]. 
Table I. Anti-inflammatory activity of test samples as judged by two different assay systems . 
alnhibition of LPS-stimulated 
NO production by macrophages (SI) 
blnhibition of IL- I p-stimulated 
IL-8 production by HGF cells 
Sam ple 
-LPS 
S ample 
-LPS LPS CC50 -Sample IC50 SI 
Benzo[b]cyclohepta[e] [ I ,4]thiazine [1] 
6 ,8-Dibromobenzo [b]cyclohepta[e] [ I ,4]thiazine [2] 
Benzo[b]cyclohept[e] [ I ,4]oxazin-6( 1 IH)-one [5] 
3-Methyl- I -trichloroacetylazulene [2b] 
3-Ethyl- I -trichloroacetylazulene [3b] 
SE 
Dexamethasone 
Indomethacin 
>463 .O 
1 8 .4 
74.9 
>37 .7 
>36.1 
(ref. 10) 
10.3 
(ref. 7) 
28 .2 
6.6 
43 .9 
>5 .6 
>6.8 
1 1 .8 
8 .7 
8 .6 
>2 .9 
3 .6 
(HM) 
>200 
>4 
>200 
>200 
>200 
(ug/ml) 
>1 1 64 
(uM) 
>1 
>10 
(~M) 
7 .3 
0.37 
>200 
>200 
>200 
(ug/ml) 
246 
( uM) 
0.000386 
>10 
>27 .5 
>10.9 
>< I .O 
>< I .O 
>2.8 
>4 .7 
>2590.6 
><1 .O 
aRAW264.7 cells were incubated for 24 hours with various concentrations of sample, and the NO released into the culture supematant, and the cell 
viability were determined to yield the selectivity index (SI) value . bHGF cells were incubated for 48 h with various concentrations of sample in the 
presence of I ng/ml IL- I ~ , and CC50 and IC50 for IL-8 production were determined to yield the SI value. 
Materials and Methods 
Materials. The following chemicals and reagents were obtained 
from the indicated companies: Dulbecco's modified Eagle's medium 
(DMEM) (GIBCO BRL, Grand Island, NY, USA); fetal bovine 
serum (FBS) , 3-(4 ,5-dimethylthiazol-2-yl)-2 ,5-diphenyltetrazolium 
bromide (MTT), LPS from Escherichia coli (serotype O111:B4) 
(Sigma-Aldrich , St . Louis , MO , USA) ; dexamethasone , 
indomethacin , dimethyl sulfoxide (DMSO) (Wako Pure Chemical 
Ltd., Osaka, Japan); interleukin (IL)-1a, IL-1p (R&D systems, 
Minneapolis, MN, USA). 
Preparations of Porphyromonas gingivalis LPS, Iipid A and synthetic 
SU63 Iipid A. The procedures for preparation of P. gingivalis Su63 
LPS and lipid A were described previously (8, 9). Briefly, the LPS 
was extracted from acetone- ried cells with phenol-water, digested 
with RNase , DNase I, and proteinase K, and then purified by 
repeated ultracentrifugation (105 ~)OO xg, 12 h, 6 times). The LPS was 
washed succe sively with phenol/chloroform/petroleum ether (2:5:8, 
v/v) and aceton  and hen lyophilized. 
Free lipid A was cov red from hydrolysates (1% acetic acid, 
100'C, I .5 hours) of LPS as de cribed previously (9) . It was purified 
by passage through a Dowex 50 (H+) column with chloroform/ 
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Table II. Effect of various stimulators on the production ofpro-inflammatory substances by HGF. HGF cells were incubated for 24, 72 or 120 h 
without (control) or with LPS (100 ng/ml), IL-1p (1 nglml) or IL-1p (1 nglml) and LPS (derivedfrom E. coli) (100 ng/ml), and the extracellular 
concentrations ofNO, TNF. PGE2, IL-6, IL-8 and MCP-1 were determined. Each value represents the mean of duplicate determinations. 
Extracellular concentration (% of control) 
Treatment Time 
(hours) NO (~M) TNF (pg/*1) PGE2 (pg/ml) IL-6 (pg/ml) IL-8 (pg/ml) MCP-1 (pg/ml) 
Control 
LPS 
IL- I ~ 
IL- I ~+LPS 
24 
72 
1 20 
24 
72 
1 20 
24 
72 
l 20 
24 
72 
1 20 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
< I .6 
<1 .6 
< I .6 
< I .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
<1 .6 
< I .6 
< I .6 
8 (100) 
4 (100) 
6 (100) 
12 (139) 
7 (187) 
6 (102) 
407 (49 1 4) 
881 (23742) 
713 (12657) 
684 (8266) 
2054 (55361) 
1467 (26063) 
18 (100) 
160 (100) 
310 (100) 
32 (178) 
155 (97) 
359 (1 16) 
262 (1458) 
742 (464) 
748 (241) 
275 (1533) 
693 (433) 
694 (224) 
77 (100) 
72 (100) 
133 (100) 
53 (69) 
119 (165) 
193 (145) 
1785 (2323) 
3081 (4280) 
3206 (2405) 
1883 (2451) 
3160 (4389) 
3423 (2568) 
10 (100) 
86 (100) 
129 (100) 
12 (111) 
122 (141) 
198 (153) 
139 (1334) 
287 (332) 
336 (260) 
165 (1582) 
277 (321) 
320 (248) 
methanol (3: I , v/v) as the eluent and gel permeation chromatography 
with a Sephadex LH-20 (Pharmacia, Uppsala, Sweden) column with 
the same solvent as the eluent. 
The synthetic SU63 Iipid A analog for P, gingivalis was prepared 
basically according to the procedure previously reported (9). The 
synthetic analog consisted of a P(1-6)-1inked D-glucosamine 
disaccharide I ,4'-bisphosphate backbone acylated with (R)-3-
hydroxy-15-methylhexadecanoic acid, (R)-3-hydroxyhexadecanoic 
acid, (R)-3-0-(hexadecanoyl)-15-methylhexadecanoic acid and (R)-
3-hydroxy-13-methyltetradecanoic acid at positions 2, 3 , 2' and 3' of 
a hydrophilic backbone. 
Preparation of azulene-related compounds. Benzo[b]cyclohepta[e] 
[1 ,4]thiazine [1] , 6,8-dibromobenzo[b]cyclohepta[e][1 ,4]thiazine 
[2] , benzo[b]cyclohept[e] [1 ,4]oxazin-6(1 IH)-one [5] , 3-methyl-1-
trichloroacetylazulene [2b] and 3-ethyl-1-trichloroacetylazulene 
[3b] were prepared as described previously (4-6). 
Preparation of SE. SE was prepared and supplied by Daiwa 
Biological Research Institute Co., Ltd., Kawasaki, Kanagawa, Japan. 
SE (21 ml) was freeze-dried to produce the powder (1 .1 g). 
Cell culture. HGF cells were established from the periodontal 
tissues of the first premolar extracted tooth in the lower jaw, as 
described previously (10, 1 1). The life-span of HGF cells was about 
40 population doubling level (PDL), and the cells at 10-20 PDL 
were used for the present study. HGF cells were cultured in DMEM 
supplemented with 10% heat-inactivated FBS, 100 units/ml 
penicillin G and I OO ug/ml streptomycin sulfate under humidified 
5% C02 atmosphere. 
Assay for cytotoxic activity. Cells were inoculated at lxl03 cells/0.1 
ml in the inner 60 wells of a 96-microwell plate (Falcon Becton 
Dickinson, Franklin Lakes, NJ, USA). The surrounding 36 exterior 
wells were filled with 0.1 ml of PBS(-) to minimize the evaporation 
of water from the culture medium. After 48 h, the medium was 
removed by suction with aspirator, and replaced with O . I ml of fresh 
medium containi g different concentrations of sample. Cells were 
incubated for 24 , 48 or 72 h, and the relative viable cell number was 
then determined by MTT method (10, 1 1). 
Assay for pro-inflammatory substances. The concentration of PGE2 
released into the culture medium was determined by enzyme 
immunoassay (EIA) (Cayman Chemical Co., Ann Arbor, MI, USA). 
Tumor necrosis factor (TNF)-a, IL-6, IL-8 and monocyte 
c emotactic protein-1 (MCP-1) released into the culture medium 
were de ermined by enzyme-linked immunosorbent assay (ELISA) 
(Quantikine ELISA kit; R&D systems). 
Effect on NO production by macrophages. RAW264.7 cells 
(6x I 04/ml) wer  inoculated to 96-microwell plates, and incubated 
for 24 h. The medium was then replaced with phenol red-free 
DMEM medium con aining 10% FBS and the indicated 
concentrations of stimulators. After incubation for 24 h, the NO 
released into the culture supernatant was measured by the Griess 
method. From the ose response curve, the 50(~o inhibitory 
concentration (IC50) was calculated. The attached cells were stained 
with MTT reagent to detenuine the CC50, as described above. The 
selectivity index (SI) for the inhibition of NO production was 
determined by the following equation: SI=CC50/IC50 (5). 
Stati tical analysis . The mean values and standard deviations were 
calculated. The average values were compared by paired t-test. The 
value of statistica  signif cance was set at the O .O 1 Ievel . 
Results 
Establishment of assay conditions. Treatment of HGF cells 
with IL- I p ( I ng/ml) resulted in one to two orders higher 
production of PGE2 , IL-6, IL-8 and MCP=1 , but induced no 
detectable amount of NO a d TNF production (Table II) . 
Addi ion of IL- Ice (1 ng/ml) alone or in combination with 
LPS or LPS with L-1~ failed to induce NO production into 
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Table 111. Effect of LPS and lipid A on the production of pro-
inflammatory substances by HGF. HGF cells were incubated for 48 h 
without (control) or with 100 ng/ml of each sample or IL-1p (1 nglml) 
and the extracellular concentrations oflL-6, IL-8 and MCP-1 were then 
determined. Each value represents the mean of duplicate determinations . 
Extracellular concentration 
(pg/ml) (% of control) 
?
~*o = ~ co ?
?
?
?
?
IL-6 IL-8 MCP- 1 
None (control) 
E, coli LPS 
P, gingivalis ATCC33277 LPS 
P. gingivalis Su63 LPS (batch 1) 
P. gingivalis Su63 LPS (batch 2) 
E. coli synthetic lipid A (506) 
P, gingivalis Su63 native lipid A 
P. gingivalis synthetic lipid A 
IL- I p 
186 (100) 
206 (109) 
222 (1 17) 
177 (94) 
186 (98) 
1 79 (94) 
165 (87) 
162 (85) 
1713 (904) 
?
?
* !~~~~~~~~~~ * * 
!?
?
?
?
?
?
?
?
?
?
?
78 (100) 95 (100) 
162 (208) 106 (112) 
33 (170) 115 (121) 
98 (125) 93 (98) 
129 (165) 101 (107) 
105 (135) 96 (101) 
115 (148) 95 (100) 
77 (98) 75 (79) 
2507 (3214) 777 (820) 
the culture medium (data not shown) . LPS derived from 
E. coli and P. gingivalis, and native and synthetic lipid A 
were substantially inactive (Table 111) . However, addition of 
LPS further enhanced the IL- I ~-induced PGE2 production, 
but not that of IL-6, IL-8 and MCP-1 (Table II). 
IL-1~ significantly (p<0.01) stimulated the IL-8 
production, reaching a plateau level after 48 h (Figure 2A). 
The production of IL-8 was increased with the concentration 
of IL- I ~ , reaching a plateau level above I ng/ml (Figure 2A) . 
IL-1~ (0.1-1000 ng/ml) did not inhibit growth of HGF cells 
(Figure 2B). Based on these data, we have adopted IL-1p at 
1 ng/ml as stimulator, and 48 h as incubation time, for the 
subsequent experiments . 
Effect of anti-inflammatory substances. The efficacy of two 
po pular anti-inflammatory drugs , dexamethasone and 
indomethacin (Figure 3), was tested first. Dexamethasone 
potently inhibited IL-8 production in IL- I p-stimulated HGF 
cells. The IC50 of dexamethasone was O .O00386 uM (Figure 
3B), and the 50% cytotoxic concentration (CC50) was above 1 
uM (Figure 3E) , yielding the selectivity index (SI=1C50/CC50) 
of >2590 .6 (Table I) . Indomethacin did not significantly affect 
the production of IL-8 production (SI ><1 .O) (Figure 3C and F) . 
We previously reported that benzo[b]cyclohepta[e] 
[ I ,4]thiazine [1] inhibited the NO-production by LPS-activated 
RAW264.7 cells (SI;z463.0), more efficiently than 6,8-
dibromobenzoLb]cyclohepta[e][1,4]thiazine [2] (SI=18.4), 
benzo[b]cycloheptLe][1 4]oxazin-6(1 IH)-one 15] (SI=74.9), 3-
methyl- I -trichloroacetylazulene [2b] (S1~37.7) and 3-ethyl- I -
uichloroacetylazulene [3b] (>36.1) (4-6, 10) (Table I). We 
confimled the potency of [1] to inhibit the NO production by 
activated macrophages , regardless of the order of administration 
O O. 1 1 1 O I OO I OOO ~ 60
c o B o ~'  20 
~~OO 
~ 80 ?
= c: 
~5 40 o o ~ (e O ~; O i 10 100 1000 0.1 
IL-1 p (nglml) 
Figure 2 Effect oflL-If  on the IL-8 production (A) and growth (B) of 
HGF cells. Near confluent HGF cells (10 PDL) virere treated for 24 (O), 
48 ([]) or 72 (A) h without (control) or with the indicated 
concentrations oflL-Ifi and the extracellular concentrations oflL-8 (A) 
and viable cell number (only at 72 h) (B) were then determined. Each 
value represents mean:tS.D. of triplicate assays. *p<0.01 compared to 
without IL-1 p. 
(whether sanrpleH>LPS or LPS-sample) (Table I) . Furthenuore, 
[1] signif cantly (p<0.01) inhibited IL-1p-induced IL-8 
production of HGF cells (Figure 3A, D), and the inhibitory 
activity of [1] (SI>27.5) exceeded that of other related 
compounds [2, 5, 2b, 3bl (SI=1 .0-10.9) (Table I). 
We previously rep rted that SE inhibited NO and PGE2 
production by activa ed macrophages [SI=10.4 (Table I) and 
4.9, respectively)] (7). ere we found that SE significantly 
(p<0.01) inhibited IL-1p-stimulated IL-8 production at 
concentrations above 50 ug/ml (Figure 4A) . The IC50 Was 
calculated to be 246 ug ml. SE slightly, but not significantly 
stimula ed the growth o  IL- I ~-treated HGF cells (CC50 
>1 164 ug/ml) (B), yiel ing an SI value of >4.7 (Table I). 
Discussio
We have established an in vitro gingivitis model, using 
cultured HGF cells stimulated by popular pro-inflammatory 
cytokine IL- I p . The extent of anti-gingivitis activity of 
sample can be monitored by the decrease of IL-8 production . 
Using this assay system, we found that dexamethasone 
(steroidal anti-inflammatory drug) inhibited IL-8 production 
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Figure 3. Effect of[1], dexamethasone and indomethacin on IL-8 production and viability of HGF cells. Near-confluent HGF cells (16 PDL) were 
treated for 48 h without (control) or with the indicated concentrations of[1] (A, D), dexamethasone (B, E) and indomethacin (C, F) together with 
IL-Ift (1 ng/ml), and the extracellular concentrations oflL-8 (A, B, C) and viable cell number (D, E, F) were then determined. Each value represents 
mean_+S.D. of triplicate assays. ~p<0.01 compared to control (without sample). 
by the activated HGF cells more efficiently than did 
indomethacin (nonsteroidal anti-inflammatory drug) . This 
supports the efficacy of corticosterones for treatment of 
stomatitis (1). We found that LPS enhanced the production 
of PGE2 by approximately two-fold, whereas it did not affect 
the production of IL-6, IL-8 and MCP-1 in IL-1 ~-stimulated 
HGF cells (Table I) . This suggests that the induction 
mechanism of PGE2 upon stimulation with IL- I p in HGF 
cells may be different from that of IL-6, IL-8 and MCP-1 . 
Azulene-related compounds, which efficiently inhibited 
NO production by activated macrophages, only marginally 
inhibited IL-8 production by activated HGF cells. This 
suggests that the anti-inflammatory action of azulenes may 
be more pronounced in macrophages where higher levels of 
NO and PGE2 generation were observed, but not in HGF 
cells where production of these pro-inflammatory substances 
were much less. 
SE, available as an over-the-counter drug, is recognized as 
being effective in treating fatigue, Iow appetite, halitosis, 
body odour and stomatitis. However, there is no scientific 
evidence that demonstrates these phenomena. SE has been 
reported to show antiseptic (12), membrane stabilising (13), 
anti-inflammatory and phagocytic (14) , radical-scavenging 
( 15-17), antibacterial and anti-viral activities. The present 
study demonstrated that SE significantly inhibited IL-8 
production by activated HGF cells, in addition to its potent 
inhibition of NO and PGE2 production by activated 
macrophages, possibly due to the presence of multiple 
components in SE. Since SE has radical scavenging activity 
and anti-viral activity (7, 16, 17), its efficacy against 
2.5 
?
E 15 ~' ?~ CO l ??
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Figure 4. Effect of SE on -1p-stimulated IL-8 production (A) and 
growth (B) of HGF cells. Near-confluent HGF cells (12 PDL) were 
treated for 48 h without (control) or with the indicated concentrations of 
SE together with IL-Ifi (1 ng/ml), and the extracellular concentrations 
of IL-8 (A) and viable cell number (B) were then determined. Each 
value represents the meand:S.D. of triplicate assays. *p<0.01 compared 
to without SE. 
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stomatitis may be much enhanced when applied orally. 
However, clinical study with patients with stomatitis is 
crucial to confirm the anti-stomatitis effect of SE. Our recent 
study has suggested that multiple components of SE may be 
associated with each other in the native state or after 
extraction with alkaline solution ( 1 7). SE can be fractionated 
by gel filtration chromatography into four fractions: 
polysaccharide , Iignin-carbohydrate complex (two peaks) and 
10w molecular polyphenol fractions (18); it remains to be 
investigated which fraction is responsible for the anti-
gingivitis activity. 
The present assay system is applicable to the search for 
anti-stomatitis substances derived from natural products, as 
well as these synthesized chemically in the laboratory, using 
dexamethasone as positive control. 
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